This topic contains a solution. Click here to go to the answer

Author Question: Anticholinergic antiemetics are not agents of choice for management of nausea and vomiting in ... (Read 58 times)

bclement10

  • Hero Member
  • *****
  • Posts: 560
Anticholinergic antiemetics are not agents of choice for management of nausea and vomiting in clients with benign prostatic hypertrophy.
 
  Indicate whether the statement is true or false.

Question 2

The nurse understands that a client benefit of using benzodiazepams as preprocedural or conscious sedation is:
 
  a. they don't cause respiratory depression.
  b. using them is less expensive than anesthesia.
  c. they produce very few adverse effects.
  d. they produce amnesia for the event.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

shailee

  • Sr. Member
  • ****
  • Posts: 392
Answer to Question 1

T

Answer to Question 2

ANS: D

Feedback
A Incorrect: This is the major adverse effect of benzodiazepams used for conscious sedation.
B Incorrect: This is not necessarily true.
C Incorrect: This is not a true statement.
D Correct: Clients do not remember the procedure or any discomfort they experienced.




bclement10

  • Member
  • Posts: 560
Reply 2 on: Jul 24, 2018
Excellent


xthemafja

  • Member
  • Posts: 348
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

There are immediate benefits of chiropractic adjustments that are visible via magnetic resonance imaging (MRI). It shows that spinal manipulation therapy is effective in decreasing pain and increasing the gaps between the vertebrae, reducing pressure that leads to pain.

Did you know?

If all the neurons in the human body were lined up, they would stretch more than 600 miles.

Did you know?

Each year in the United States, there are approximately six million pregnancies. This means that at any one time, about 4% of women in the United States are pregnant.

Did you know?

According to the CDC, approximately 31.7% of the U.S. population has high low-density lipoprotein (LDL) or "bad cholesterol" levels.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library